Charles Robb

2020

In 2020, Charles Robb earned a total compensation of $2.9M as Chief Business Officer and Secretary at Corcept Therapeutics, a 12% increase compared to previous year.

Compensation breakdown

Bonus$321,236
Option Awards$2,118,822
Salary$474,380
Total$2,914,438

Robb received $2.1M in option awards, accounting for 73% of the total pay in 2020.

Robb also received $321.2K in bonus and $474.4K in salary.

Rankings

In 2020, Charles Robb's compensation ranked 3,974th out of 13,090 executives tracked by ExecPay. In other words, Robb earned more than 69.6% of executives.

ClassificationRankingPercentile
All
3,974
out of 13,090
70th
Division
Manufacturing
1,592
out of 5,618
72nd
Major group
Chemicals And Allied Products
603
out of 2,251
73rd
Industry group
Drugs
521
out of 1,951
73rd
Industry
Pharmaceutical Preparations
395
out of 1,456
73rd
Source: SEC filing on April 22, 2021.

Robb's colleagues

We found four more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2020.

2020

Joseph Belanoff

Corcept Therapeutics

Chief Executive Officer

2020

Sean Maduck

Corcept Therapeutics

Chief Commercial Officer

2020

Hazel Hunt

Corcept Therapeutics

Chief Scientific Officer

2020

Andreas Grauer

Corcept Therapeutics

Chief Medical Officer

News

In-depth

You may also like